Home Ruikang Pharmaceutical Clarifies No Agreement Signed with AstraZeneca for Evusheld (Tixagevimab/Cilgavimab) Mainland China Distribution Rights

Ruikang Pharmaceutical Clarifies No Agreement Signed with AstraZeneca for Evusheld (Tixagevimab/Cilgavimab) Mainland China Distribution Rights

Jul 07, 2022 18:45 CST Updated 23:31
AstraZeneca

Biopharmaceutical Manufacturer

Realcan Pharmaceutical Group Co., Ltd.: As of the date of this announcement, the company has not signed any agreement with AstraZeneca regarding the agency of Evusheld in mainland China.